| Revenues | $11.81B+0.9% | $11.70B+0.2% | $11.68B |
| Cost of revenues | -$8.78B-1.7% | -$8.63B+3.1% | -$8.91B |
| Gross profit | $3.03B-1.2% | $3.07B+10.9% | $2.77B |
| Selling, general and administrative expenses | -$1.13B-19.5% | -$944.0M-5.1% | -$898.0M |
| Gain on disposal of long-lived assets | $15.0M-78.9% | $71.0M+121.9% | $32.0M |
| Loss on impairments | -$15.0M-650.0% | -$2.0M+86.7% | -$15.0M |
| Operating income | $1.91B-13.2% | $2.19B+16.3% | $1.89B |
| Interest expense, net | -$413.0M+19.3% | -$512.0M+6.7% | -$549.0M |
| Other non-operating income (expense), net | $4.0M+107.3% | -$55.0M-52.8% | -$36.0M |
| Income before income tax expense and income from equity method investments | $1.50B-8.0% | $1.63B+24.9% | $1.30B |
| Income tax expense | -$326.0M+11.4% | -$368.0M-1.9% | -$361.0M |
| Income from equity method investments | $11.0M-15.4% | $13.0M+0.0% | $13.0M |
| Net income | $1.18B-7.1% | $1.27B+33.3% | $955.0M |
| Net loss attributable to noncontrolling interest | $3.0M+200.0% | $1.0M+0.0% | $1.0M |
| Net income attributable to the Company | $1.19B-7.0% | $1.27B+33.3% | $956.0M |
| Basic (in dollars per share) | $2.1M-7.0% | $2.3M+32.9% | $1.7M |
| Diluted (in dollars per share) | $2.1M-7.0% | $2.3M+32.9% | $1.7M |
| Basic (in shares) | $553.1M+0.0% | $553.1M+0.0% | $553.1M |
| Diluted (in shares) | $553.6M+0.1% | $553.1M+0.0% | $553.1M |
